Error: Could not add to watchlist. X

Pluristem Therapeutics Inc

+ Watchlist
PSTI:US
NASDAQ CM
2.73
USD
0.00
0.00%
As of 20:10:00 ET on 06/02/2015.
Open
2.75
Day Range
2.71 - 2.77
Volume
200,457
Previous Close
2.73
52Wk Range
2.32 - 3.78
1 Yr Return
-17.02%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.37
Market Cap (m USD)
194.887
Shares Outstanding (m)
71.387
Price/Sales (TTM)
493.65
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.
ADDRESS
Matam Advanced Technology Park
Building 20
Haifa, 31905
Israel
PHONE
972-74-710-7171
  • Zami Aberman
    Chairman/CEO
  • Yaky Yanay
    President/CFO/COO
Show More